Athero Review - Issue 1/2020
Guidelines
8
Homocysteine consensus
Ján Lietava, Pavel Blažíček, Martin Čaprnda, Katarína Rašlová, Jana Tisoňová, Branislav Vohnout
16
Comments on the new recommendations for dyslipidemia and cardiovascular risk management with regard to diabetes mellitus
Branislav Vohnout, Rid Bugáňová
22
Hypercholesterolemia as a risk factor for hearing loss: Do we have sufficient evidence?
Zuzana Capová, Lukáš Varga
27
Uric acid and influence of hyperuricaemia therapy on prevention of atheroscleroris and cardiovascular diseases
Ubica Cibičková, Martin Žurek
37
Pitfalls of diet therapy in dyslipidemias
Věra Boháčová, Tamara Starnovská
clinical studies
47
Characteristics of patients with uncontrolled arterial hypertension and/or dyslipidemia in primary care in Czechia– LipitenCliDec Study: 1st phase results
Martin Šatný, Jana Mašková, Eva Tůmová, Jiří Laštůvka, Michal Vrablík
Athero Review
2020 Issue 1
Most read in this issue
- Uric acid and influence of hyperuricaemia therapy on prevention of atheroscleroris and cardiovascular diseases
- Comments on the new recommendations for dyslipidemia and cardiovascular risk management with regard to diabetes mellitus
- Homocysteine consensus
- Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents